Brian Slocum Vannah

Title: Brian Slocum Vannah: Innovator in Clinical Trial Prediction

Introduction

Brian Slocum Vannah is an accomplished inventor based in Denver, CO. He has made significant contributions to the field of clinical trials through his innovative patent. His work focuses on enhancing the prediction of clinical trial signals, which is crucial for improving the efficacy and safety of medical treatments.

Latest Patents

Brian holds a patent titled "Early prediction of clinical trial signals." This patent encompasses methods and systems, including computer programs encoded on computer storage media, designed to detect signals related to subjects participating in clinical trials. The system collects clinical data from multiple sources, standardizes and redacts personally identifiable information, and determines predictive features that correlate with efficacy and safety signals. The computer utilizes training data to train machine learning models, predicting both efficacy and safety signals for trial subjects. It also allows for real-time updates based on user reviews of the predicted signals.

Career Highlights

Brian is currently employed at IQVIA Inc., a leading company in the field of healthcare data analytics. His role involves leveraging advanced technologies to improve clinical trial processes. His innovative approach has positioned him as a key player in the industry, contributing to more efficient and effective clinical trials.

Collaborations

Brian collaborates with talented professionals in his field, including Gary Shorter and Naouel Baili Benabdallah. These collaborations enhance the development and implementation of innovative solutions in clinical trial methodologies.

Conclusion

Brian Slocum Vannah is a notable inventor whose work in predicting clinical trial signals is paving the way for advancements in medical research. His contributions are vital for the future of clinical trials and patient safety.